Micropos Medical AB (publ) reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was SEK 0.222 million compared to SEK 0.369 million a year ago. Revenue was SEK 0.457 million compared to SEK 0.924 million a year ago. Net loss was SEK 5.24 million compared to SEK 4.17 million a year ago. Basic loss per share from continuing operations was SEK 0.04 compared to SEK 0.04 a year ago.
For the six months, sales was SEK 0.602 million compared to SEK 1.48 million a year ago. Revenue was SEK 0.938 million compared to SEK 2.2 million a year ago. Net loss was SEK 9.56 million compared to SEK 7.39 million a year ago. Basic loss per share from continuing operations was SEK 0.08 compared to SEK 0.06 a year ago.